KemPharm

+$0.02 (+0.43%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KemPharm and other ETFs, options, and stocks.

About KMPH

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy.

CEO
Travis C. Mickle
Employees
24
Headquarters
Celebration, Florida
Founded
2006

KMPH Key Statistics

Market cap
160.07M
Price-Earnings ratio
—
Dividend yield
—
Average volume
699.36K
High today
$4.77
Low today
$4.26
Open price
$4.67
Volume
3.87M
52 Week high
$14.47
52 Week low
$4.00

KMPH Earnings

-$1.61
-$1.00
-$0.39
$0.22
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure